FAM215A and Parkinson disease: It has been reported that neuronal loss may be caused due to increased cytokines and apoptosis-related proteins via the activation of NF-κB in reactive astrocytes of the substantia nigra after MPTP treatment in mice45 and the NF-κB as a Target for Therapy in Parkinson’s Disease has already been revealed previously46.